Published in Curr Biol on December 01, 1994
Understanding protein non-folding. Biochim Biophys Acta (2010) 4.33
The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry (1999) 3.98
Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J (2001) 3.22
The GSK3 hypothesis of Alzheimer's disease. J Neurochem (2007) 3.16
Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res (2006) 3.12
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest (2004) 2.80
The unfoldomics decade: an update on intrinsically disordered proteins. BMC Genomics (2008) 2.72
Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci U S A (2000) 2.34
The links between axin and carcinogenesis. J Clin Pathol (2005) 2.07
A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcription. Cancer Res (2010) 2.05
An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J Cell Biol (2002) 1.78
Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol (2008) 1.65
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev (2013) 1.52
Insulin resistance and Alzheimer's disease. BMB Rep (2009) 1.49
Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models. FASEB J (2009) 1.42
The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol Biol Cell (1998) 1.41
ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat Commun (2014) 1.24
Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease. PLoS Genet (2010) 1.23
Deconstructing GSK-3: The Fine Regulation of Its Activity. Int J Alzheimers Dis (2011) 1.22
Structural genomics analysis of alternative splicing and application to isoform structure modeling. Proc Natl Acad Sci U S A (2005) 1.15
Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol Cell Biol (2006) 1.14
Tau-based treatment strategies in neurodegenerative diseases. Neurotherapeutics (2008) 1.13
Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease. Am J Pathol (2003) 1.10
Microtubule-associated protein tau is essential for long-term depression in the hippocampus. Philos Trans R Soc Lond B Biol Sci (2013) 1.10
Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Hum Mol Genet (2008) 1.09
The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol (2013) 1.05
Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice. EMBO J (2007) 1.04
Is abnormal axonal transport a cause, a contributing factor or a consequence of the neuronal pathology in Alzheimer's disease? Future Neurol (2009) 1.02
Crowded cell-like environment accelerates the nucleation step of amyloidogenic protein misfolding. J Biol Chem (2009) 1.01
Changes in the ageing brain in health and disease. Philos Trans R Soc Lond B Biol Sci (1997) 1.01
Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo. Oncogene (2011) 0.97
GSK-3 in Neurodegenerative Diseases. Int J Alzheimers Dis (2011) 0.97
The thioredoxin-like protein rod-derived cone viability factor (RdCVFL) interacts with TAU and inhibits its phosphorylation in the retina. Mol Cell Proteomics (2009) 0.96
Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation. Int J Alzheimers Dis (2011) 0.94
Dexras1 interacts with FE65 to regulate FE65-amyloid precursor protein-dependent transcription. J Biol Chem (2008) 0.93
NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy. J Clin Invest (2010) 0.92
Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly. Biochem J (1997) 0.92
Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies. Front Mol Neurosci (2011) 0.91
Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level. Mol Neurodegener (2012) 0.90
The role of APP proteolytic processing in lipid metabolism. Exp Brain Res (2011) 0.90
Tau protein modifications and interactions: their role in function and dysfunction. Int J Mol Sci (2014) 0.89
Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease. Free Radic Biol Med (2013) 0.89
Advances in the pathogenesis of Alzheimer's disease: focusing on tau-mediated neurodegeneration. Transl Neurodegener (2012) 0.88
Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E. J Biol Chem (2010) 0.88
TIPsy tour guides: how microtubule plus-end tracking proteins (+TIPs) facilitate axon guidance. Front Cell Neurosci (2015) 0.87
Fleshing out the amyloid cascade hypothesis: the molecular biology of Alzheimer's disease. Dialogues Clin Neurosci (2000) 0.87
Phosphorylated tau can promote tubulin assembly. Proc Natl Acad Sci U S A (1999) 0.86
Overexpression screen in Drosophila identifies neuronal roles of GSK-3 beta/shaggy as a regulator of AP-1-dependent developmental plasticity. Genetics (2008) 0.86
Tau acts as a mediator for Alzheimer's disease-related synaptic deficits. Eur J Neurosci (2014) 0.85
β-Amyloid regulates leptin expression and tau phosphorylation through the mTORC1 signaling pathway. J Neurochem (2010) 0.85
Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease. Sci Rep (2015) 0.84
IGF-IR in neuroprotection and brain tumors. Front Biosci (Landmark Ed) (2009) 0.83
The marine natural-derived inhibitors of glycogen synthase kinase-3beta phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling. Bioorg Med Chem (2009) 0.82
Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal. World J Diabetes (2015) 0.80
Modulation of tau phosphorylation and intracellular localization by cellular stress. Biochem J (2000) 0.79
Hyperactivation of mitogen-activated protein kinase increases phospho-tau immunoreactivity within human neuroblastoma: additive and synergistic influence of alteration of additional kinase activities. Cell Mol Neurobiol (1999) 0.79
Platelet biomarkers in Alzheimer's disease. World J Psychiatry (2012) 0.78
A novel GSK-3β inhibitor YQ138 prevents neuronal injury induced by glutamate and brain ischemia through activation of the Nrf2 signaling pathway. Acta Pharmacol Sin (2016) 0.78
Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate. Brain (2016) 0.78
GSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individuals. PLoS One (2013) 0.77
Modification of the Drosophila model of in vivo Tau toxicity reveals protective phosphorylation by GSK3β. Biol Open (2014) 0.77
Amyloid-β-Induced Dysregulation of AMPA Receptor Trafficking. Neural Plast (2016) 0.77
Silencing [Formula: see text] Rescues Tau Pathologies and Memory Deficits through Rescuing PP2A and Inhibiting GSK-3β Signaling in Human Tau Transgenic Mice. Front Aging Neurosci (2014) 0.77
An X11alpha/FSBP complex represses transcription of the GSK3beta gene promoter. Neuroreport (2010) 0.77
Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers. Sci Rep (2015) 0.77
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes. BMC Cancer (2014) 0.76
Tibolone modulates neuronal plasticity through regulating Tau, GSK3β/Akt/PI3K pathway and CDK5 p35/p25 complexes in the hippocampus of aged male mice. Neural Regen Res (2017) 0.76
Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease. eNeuro (2017) 0.75
Compartmental protein expression of Tau, GSK-3beta and TrkA in cholinergic neurons of aged rats. J Neural Transm (Vienna) (2006) 0.75
AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo. Sci Rep (2016) 0.75
NSE-controlled carboxyl-terminus of APP gene over-expressing in transgenic mice induces altered expressions in behavior, Abeta-42, and GSK3beta binding proteins. Cell Mol Neurobiol (2005) 0.75
Induction of immunological tolerance by porcine liver allografts. Nature (1969) 5.89
Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants. Nature (1982) 4.93
Plasmodium vivax resistance to chloroquine? Lancet (1989) 4.51
Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J (1998) 4.46
All classes of intermediate filaments share a common antigenic determinant defined by a monoclonal antibody. Cell (1981) 4.28
The complete primary structure of protein kinase C--the major phorbol ester receptor. Science (1986) 4.02
The effects of HIV/AIDS intervention groups for high-risk women in urban clinics. Am J Public Health (1994) 3.37
Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett (1992) 2.85
Immunodeficiency in protein kinase cbeta-deficient mice. Science (1996) 2.79
Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother (1984) 2.40
The release of growth arrest by microinjection of adenovirus E1A DNA. EMBO J (1985) 2.32
Ninety-seven million years of angiosperm-insect association: paleobiological insights into the meaning of coevolution. Proc Natl Acad Sci U S A (1994) 2.32
Pleiotropic control of glucose and hormone responses by PRL1, a nuclear WD protein, in Arabidopsis. Genes Dev (1998) 2.23
Down-regulation of protein kinase C is due to an increased rate of degradation. Biochem J (1987) 2.14
Prolonged survival of liver transplants in the pig. Br Med J (1967) 2.14
Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA (1995) 2.12
Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein. Proc Natl Acad Sci U S A (1997) 2.11
Activation of the c-Raf protein kinase by protein kinase C phosphorylation. Oncogene (1992) 2.04
Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Br J Pharmacol (1988) 2.02
Alzheimer's disease: immunoreactivity of neurofibrillary tangles with anti-neurofilament and anti-paired helical filament antibodies. Brain Res (1984) 1.98
Purification to homogeneity of protein kinase C from bovine brain--identity with the phorbol ester receptor. EMBO J (1984) 1.97
Monoclonal antibodies to mammalian neurofilaments. Biosci Rep (1981) 1.96
Patterns of non-response to a mail survey. J Clin Epidemiol (1990) 1.87
Hippocampal and neocortical ubiquitin-immunoreactive inclusions in amyotrophic lateral sclerosis with dementia. Neurosci Lett (1992) 1.82
Protein kinase C--a family affair. Mol Cell Endocrinol (1989) 1.81
Integration sites of adenovirus type 12 DNA in transformed hamster cells and hamster tumor cells. J Virol (1980) 1.79
Ubiquitin deposits in anterior horn cells in motor neurone disease. Neurosci Lett (1988) 1.77
Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol (1994) 1.75
Ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis. Morphology, distribution, and specificity. Brain (1991) 1.74
AIDS/HIV risk behavior among the chronic mentally ill. Am J Psychiatry (1992) 1.72
Stabilization of the anticodon stem-loop of tRNALys,3 by an A+-C base-pair and by pseudouridine. J Mol Biol (1999) 1.70
New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry. J Neurochem (1998) 1.69
A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm Res (1990) 1.64
A monoclonal antibody against neurofilament protein specifically labels a subpopulation of rat sensory neurones. J Comp Neurol (1984) 1.63
Physical activity and self-reported, physician-diagnosed osteoarthritis: is physical activity a risk factor? J Clin Epidemiol (2000) 1.59
Brain diseases. Ubiquitous variations in nerves. Nature (1989) 1.53
Hypermodified nucleosides in the anticodon of tRNALys stabilize a canonical U-turn structure. Biochemistry (2000) 1.51
Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J Cell Sci (1996) 1.49
Human homologues of the bacterial heat-shock protein DnaJ are preferentially expressed in neurons. Biochem J (1992) 1.47
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol (2003) 1.44
Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site. Biochem J (1991) 1.42
Synthesis and studies on the effect of 2-thiouridine and 4-thiouridine on sugar conformation and RNA duplex stability. Nucleic Acids Res (1997) 1.42
Recent military experience with malaria chemoprophylaxis. Med J Aust (1993) 1.41
Conformational flexibility in RNA: the role of dihydrouridine. Nucleic Acids Res (1996) 1.41
Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene (1994) 1.38
Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470. Cancer Res (2001) 1.38
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY: ABNORMAL SPLITTING OF ETHYL GROUPS DUE TO MOLECULAR ASSYMETRY. Proc Natl Acad Sci U S A (1961) 1.38
Protein kinase C and mammary cell differentiation: involvement of protein kinase C alpha in the induction of beta-casein expression. Cell Growth Differ (1994) 1.37
Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett (1999) 1.36
Selectivity in integration sites of adenoviral DNA. Cold Spring Harb Symp Quant Biol (1980) 1.35
Site of linkage between adenovirus type 12 and cell DNAs in hamster tumour line CLAC3. Nature (1981) 1.34
Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc Natl Acad Sci U S A (1996) 1.34
Immunosuppressive effects of the orthotopically transplanted porcine liver. Transplant Proc (1969) 1.34
Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules. Neuroscience (1996) 1.33
Glutamate slows axonal transport of neurofilaments in transfected neurons. J Cell Biol (2000) 1.33
Neuronal filaments in Alzheimer's, Pick's, and Parkinson's diseases. N Engl J Med (1985) 1.32
In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3beta. J Neurochem (1996) 1.31
Regulation of 70-kDa heat-shock-protein ATPase activity and substrate binding by human DnaJ-like proteins, HSJ1a and HSJ1b. Eur J Biochem (1994) 1.29
Citrate utilization by Escherichia coli: plasmid- and chromosome-encoded systems. J Bacteriol (1983) 1.28
Alzheimer neurofibrillary tangles contain phosphorylated and hidden neurofilament epitopes. J Neurol Neurosurg Psychiatry (1986) 1.27
Intermediate filaments: a family of homologous structures. J Muscle Res Cell Motil (1981) 1.27
Effect of donor antigen on dogs with renal homotransplants. Transplantation (1966) 1.27
Quantitation of protein kinase C by immunoblot--expression in different cell lines and response to phorbol esters. J Cell Physiol (1987) 1.25
Interactions of valproic acid with phenytoin. Neurology (1980) 1.24
3'-Azido-2',3'-dideoxyuridine (AzddU): comparative pharmacokinetics with 3'-azido-3'-deoxythymidine (AZT) in monkeys. AIDS Res Hum Retroviruses (1990) 1.24
Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha. J Biol Chem (1993) 1.23
Nitrocellulose-bound antigen repeatedly used for the affinity purification of specific polyclonal antibodies for screening DNA expression libraries. J Immunol Methods (1988) 1.23
Studies on the phosphorylation of protein kinase C-alpha. Biochem J (1992) 1.22
Hsp40 molecules that target to the ubiquitin-proteasome system decrease inclusion formation in models of polyglutamine disease. Mol Ther (2007) 1.22
Diet and retarded growth. Br Med J (1978) 1.21
The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience (1997) 1.21
On the mechanism of recombination between adenoviral and cellular DNAs: the structure of junction sites. Curr Top Microbiol Immunol (1984) 1.20
Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol (2001) 1.20
Nucleotide sequence at the site of junction between adenovirus type 12 DNA and repetitive hamster cell DNA in transformed cell line CLAC1. Nucleic Acids Res (1982) 1.20
Expression of protein kinase C isotypes using baculovirus vectors. Methods Enzymol (1991) 1.20
Anion-binding to liver alcohol dehydrogenase, studied by rate of alkylation. Eur J Biochem (1969) 1.19
Multiplex detection and quantitation of proteins on western blots using fluorescent probes. Biotechniques (2000) 1.19
Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease. J Neurochem (1993) 1.18
Differences between chimpanzees (Pan troglodytes) and humans (Homo sapiens) in the resting state of the index finger: implications for pointing. J Comp Psychol (1994) 1.18
Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease. Acta Neuropathol (1988) 1.17
Liver preservation by single passage hypothermic "squirt" perfusion. Br Med J (1972) 1.17
Pick's disease: an immunocytochemical study of neuronal changes. Monoclonal antibodies show that Pick bodies share antigenic determinants with neurofibrillary tangles and neurofilaments. Acta Neuropathol (1983) 1.16
The polypeptides of isolated brain 10nm filaments and their association with polymerized tubulin. Biochem J (1979) 1.16
Rapid radioimmunoassay for corticotropin in unextracted human plasma. Clin Chem (1984) 1.15
Preservation of the porcine liver. Transplant Proc (1974) 1.13
New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol (1989) 1.12
Stress-activated protein kinase/c-jun N-terminal kinase phosphorylates tau protein. J Neurochem (1997) 1.11
Cytoskeletal abnormalities in motor neuron disease. An immunocytochemical study. Brain (1989) 1.10
Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J Cell Sci (2000) 1.10
Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents. Biochem Pharmacol (1997) 1.09
Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonists. Biochem J (1995) 1.09
Activation of casein kinase II by sphingosine. J Biol Chem (1991) 1.09
Muscular strength and physical function. Med Sci Sports Exerc (2000) 1.09
Highly regulated cell type-restricted expression of human renin in mice containing 140- or 160-kilobase pair P1 phage artificial chromosome transgenes. J Biol Chem (1999) 1.09